SSNC 49.90 SS&C Technologies Holdings $SSNC Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SSNC 49.90 SS&C Technologies Holdings $SSNC Hit a 52 week high of 50.00 Currently at 49.90 -0.09 -0.18% With a day low of 49.46 and a total volume of 4,324.

SSNC SS&C Technologies Holdings Recent Headline News

SS&C Announces Executive Promotions to Strengthen Private Equity and EMEA Alternative Assets Teams
GlobeNewswire - Thu Nov 06, 8:45AM CST
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, today announced key executive promotions to further extend its focus and capabilities in both its private equity software and fund administration services businesses.
SSNC: 49.98 (-0.01)

SS&C's New Release of SS&C PORTIA Helps Asset Managers With Global Accounting Operations
GlobeNewswire - Tue Nov 04, 8:01AM CST
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, is pleased to announce the latest release of SS&C PORTIA, a leading middle-to-back office investment operations platform.
SSNC: 49.98 (-0.01)

MoneyGram Earnings Plunge Yet Again, Shares Crash 32% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 9:00AM CST
MoneyGram International Inc.'s (MGI) third-quarter 2014 operating earnings fell short of the Zacks Consensus Estimate and was lower than the year-ago quarter figure on weak top line.
PRAA: 61.23 (-2.62), MGI: 8.35 (-0.02), SSNC: 49.98 (-0.01), WMT: 79.00 (-0.44)

SS&C Technologies Holdings' (SSNC) CEO William Stone on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 7:30PM CDT

SSNC: 49.98 (-0.01)

SS&C Technologies Holdings (SSNC) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 29, 3:55PM CDT

SSNC: 49.98 (-0.01)

SS&C Technologies Holdings beats by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:47PM CDT

SSNC: 49.98 (-0.01)

SS&C Technologies Reports Q3 2014 Results
GlobeNewswire - Wed Oct 29, 3:12PM CDT
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of investment and financial software-enabled services and software, today announced its financial results for the quarter that ended September 30, 2014.
SSNC: 49.98 (-0.01)

SS&C PORTIA Launches Explorer for Customized Reporting
GlobeNewswire - Tue Oct 28, 8:00AM CDT
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, today released Explorer, a powerful data visualization and analysis tool that turns critical investment data into meaningful information.
SSNC: 49.98 (-0.01)

SS&C Technologies meets EI3PA compliance under PCI DSS standard
M2 - Mon Oct 27, 6:26AM CDT
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC) said that it has successfully completed its Experian Independent Third Party Assessment certification utilizing the Payment Card Industry Data Security Standard (PCI-DSS) framework.
SSNC: 49.98 (-0.01)

SS&C Technologies Finalizes PCI-DSS and EI3PA Security Assessments
GlobeNewswire - Fri Oct 24, 8:00AM CDT
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, today announced that it has successfully completed its Experian Independent Third Party Assessment (EI3PA) certification utilizing the Payment Card Industry Data Security Standard (PCI-DSS) Framework. These technical and operational assessments are designed to help protect consumer information.
SSNC: 49.98 (-0.01)

SS&C GlobeOp Forward Redemption Indicator: October Notifications 3.12%
GlobeNewswire - Tue Oct 21, 3:00AM CDT
The SS&C GlobeOp Forward Redemption Indicator for October 2014 measured 3.12%, down from 3.25% in September.
SSNC: 49.98 (-0.01)

SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index
GlobeNewswire - Mon Oct 13, 3:00AM CDT
The gross return of the SS&C GlobeOp Hedge Fund Performance Index for September 2014 measured 0.24%.
SSNC: 49.98 (-0.01)

SS&C Technologies 2014 Third Quarter Earnings Release Notice
GlobeNewswire - Wed Oct 08, 9:00AM CDT
SS&C Technologies (Nasdaq:SSNC), a global provider of investment and financial software-enabled services and software, will announce its financial results for the third quarter ended September 30, 2014 after the close of the market on Wednesday, October 29, 2014. The earnings conference call, scheduled for Wednesday, October 29 at 5:00 p.m. Eastern Time, will discuss third quarter results.
SSNC: 49.98 (-0.01)

SS&C Unveils Integrated Front- to Back-Office Solution for Hedge Funds
GlobeNewswire - Wed Oct 08, 8:00AM CDT
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, today unveiled its integrated front- to back-office technology platform for hedge funds.
SSNC: 49.98 (-0.01)

SS&C Hires Stewart Bent to Head Up Fund Services in Asia
GlobeNewswire - Tue Sep 30, 8:01AM CDT
SS&C Technologies Holdings, Inc. (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, today announced that Stewart Bent has been tapped to manage SS&C GlobeOp's fund administration business in Asia.
SSNC: 49.98 (-0.01)

SS&C Technologies to Present at Deutsche Bank Leveraged Finance Conference
GlobeNewswire - Mon Sep 29, 10:29AM CDT
SS&C Technologies (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, announced today that Patrick Pedonti, Chief Financial Officer, will speak at the Deutsche Bank 22 Annual Leveraged Finance Conference on Wednesday, October 1 at The Pheonician in Scottsdale, AZ at 9:25 AM MST.
SSNC: 49.98 (-0.01), DB: 30.11 (+0.11)

SS&C GlobeOp Forward Redemption Indicator: September Notifications 3.25%
GlobeNewswire - Mon Sep 22, 2:59AM CDT
The SS&C GlobeOp Forward Redemption Indicator for September 2014 measured 3.25%, down from 4.19% in August.
SSNC: 49.98 (-0.01)

SS&C Technologies to Present at Deutsche Bank Technology Conference
GlobeNewswire - Tue Sep 09, 8:03AM CDT
SS&C Technologies (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, announced today that Patrick Pedonti, Chief Financial Officer, will speak at the Deutsche Bank Technology Conference on Thursday, September 11 at The Cosmopolitan Las Vegas in Las Vegas, NV at 8:50 AM PDT.
SSNC: 49.98 (-0.01), DB: 30.11 (+0.11)

SS&C Technologies CEO is Keynote Speaker AGC Partners' Digital, Mobile & Fintech Growth Conference
GlobeNewswire - Mon Sep 08, 9:11AM CDT
SS&C Technologies (Nasdaq:SSNC), a global provider of financial services software and software-enabled services, announced today that Bill Stone, Chairman and Chief Executive Officer, will be the keynote speaker at AGC Partners' Digital, Mobile & Fintech Growth Conference on on Tuesday, September 9 at The W Hotel Union Square in New York, NY at 12:15 PM ET. Mr. Stone will also be participating on the Fintech M&A panel at 11:15 AM ET.
SSNC: 49.98 (-0.01)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 21

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 33

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 344

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 239

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading